日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

PD-L1 on large extracellular vesicles is a predictive biomarker for therapy response in tissue PD-L1-low and -negative patients with non-small cell lung cancer

PD-L1 在大细胞外囊泡上的表达是预测非小细胞肺癌组织中 PD-L1 低表达和阴性患者治疗反应的生物标志物。

Nadja Schöne ,Marcel Kemper ,Kerstin Menck ,Georg Evers ,Carolin Krekeler ,Arik Bernard Schulze ,Georg Lenz ,Eva Wardelmann ,Claudia Binder ,Annalen Bleckmann

Regulation of HHLA2 expression in kidney cancer and myeloid cells

肾癌和髓系细胞中HHLA2表达的调控

Tomonari Shigemura ,Nahuel Perrot ,Zimo Huang ,Rupal S Bhatt ,Aseman Bagheri Sheshdeh ,Nourhan El Ahmar ,Fatme Ghandour ,Sabina Signoretti ,David F McDermott ,Gordon J Freeman ,Kathleen M Mahoney

Transcriptome Sequencing (RNAseq) Enables Utilization of Formalin-Fixed, Paraffin-Embedded Biopsies with Clear Cell Renal Cell Carcinoma for Exploration of Disease Biology and Biomarker Development

转录组测序 (RNAseq) 可利用福尔马林固定、石蜡包埋的透明细胞肾细胞癌活检样本来探索疾病生物学和生物标志物的发展

Oystein Eikrem, Christian Beisland, Karin Hjelle, Arnar Flatberg, Andreas Scherer, Lea Landolt, Trude Skogstrand, Sabine Leh, Vidar Beisvag, Hans-Peter Marti